| Financial Year |
March 31 2023 |
| Monetary Funds |
197,126,058.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
174,540,511.93 |
| Advances to Suppliers |
259,455,567.71 |
| Other Receivables |
45,236,168.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,264,505.84 |
| Inventories |
1,077,832,785.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,532,427.16 |
| Total Current Assets |
1,808,994,322.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,611,844.19 |
| Long-term Equity Investment |
445,625,730.51 |
| Investment Properties |
195,579,549.77 |
| Fixed Assetes |
623,130,772.38 |
| Under-construction Projects |
13,134,904.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
278,125,005.93 |
| R&D expenses |
-- |
| Goodwill |
48,452,321.84 |
| Long-Term Deferred and Prepaid Expenses |
31,235,841.92 |
| Deferred Income Tax Assets |
18,119,423.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,807,814,933.43 |
| Total Assets |
3,616,809,255.61 |
| Short-Term Loans |
503,247,194.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,007,144.00 |
| Accounts Payable |
103,008,728.69 |
| Accounts Received In Advance |
1,103,302.75 |
| Employee Compensation Payable |
20,473,481.12 |
| Taxes Payable |
36,843,822.47 |
| Interest Payable |
-- |
| Dividend Payable |
3,528,336.39 |
| Other payables |
470,036,802.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
93,999,259.99 |
| Other Current Liabilities |
7,774,973.52 |
| Sub-Total of Current Liabilities |
1,434,420,691.68 |
| Long-term Loans |
791,250,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
589,894.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
59,679,955.91 |
| Deferred Income Tax Liabilities |
29,916,971.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
969,926,972.77 |
| Total Liabilities |
2,404,347,664.45 |
| Paid-In Capital(Or Share Stock) |
1,946,380,317.00 |
| Capital Surplus |
355,909,690.96 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,323,135,555.76 |
| Minority Stockholder's Interest |
239,331,704.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
973,129,886.50 |
| Owner's Equity（Stockholder's Equity） |
1,212,461,591.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,616,809,255.61 |
